Schrödinger, Inc. (Nasdaq: SDGR) today announced the appointment of Bridget van Kralingen to its Board of Directors, effective March 7, 2025. This press release features multimedia. View the full ...
IBM CEO Ginni Rometty picked van Kralingen to oversee some of Big Blue’s most strategic businesses to help spur growth, including the company’s nascent blockchain unit. She also manages some ...
Schrodinger, Inc. (NASDAQ:SDGR), a pharmaceutical technology company with a market capitalization of $1.54 billion, announced on Monday the appointment of Bridget van Kralingen to its Board of ...
Van Kralingen, a senior partner at Motive Partners and a former executive at IBM, brings over three decades of experience in leading global technology and software businesses. According to ...
Schrödinger, Inc. today announced the appointment of Bridget van Kralingen to its Board of Directors, effective March 7, 2025 ...
Schrodinger, Inc. (NASDAQ:SDGR), a pharmaceutical technology company with a market capitalization of $1.54 billion, announced on Monday the appointment of Bridget van Kralingen to its Board of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback